20. august 2007

Tähelepanu! Artikkel on enam kui 5 aastat vana ning kuulub väljaande digitaalsesse arhiivi. Väljaanne ei uuenda ega kaasajasta arhiveeritud sisu, mistõttu võib olla vajalik kaasaegsete allikatega tutvumine.

<br /><strong>Occlutech Initiates Non-Infringement Proceedings and Filesfor Invalidation of AGA Medical's European Patent in theU.K.</strong>

Occlutech GmbH- the leading European manufacturer of cardiacocclusion devices such as ASD- PFO and LAA occluders todayannounced that it has initiated invalidation proceedings againstAGA's European patent in the U.K. Most of the broader claimsinterpreted into this patent by AGA Medical were not accepted bythe examiners of the European Patent Office in the original patentapproval process due to the existence of prior art. This creates asignificant and justified basis for Occlutech to file forinvalidation.